11.08.2026 ImmuneBridge and Repairon Immuno have entered into a research collaboration

ImmuneBridge and Repairon Immuno have entered into a research collaboration to evaluate the potential of ImmuneBridge’s proprietary small molecule IBR403 to enhance the expansion of iPSC-derived hematopoietic stem cells (HSCs).

The collaboration combines ImmuneBridge’s expertise in small-molecule-enabled HSC expansion and scalable immune-cell manufacturing with Repairon Immuno’s expertise in clinically tested iPSC technology, hematopoietic differentiation and the development of HSC-derived cellular products.

Together, the companies will explore whether the approach can improve the yield and quality of iPSC-derived HSCs while preserving their capacity to generate diverse immune-cell lineages and reconstitute a healthy, functional immune system.